Bionik Laboratories Corp. Stock
Stocks
BNKL
US09074A2087
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000100 USD | +9,900.00% |
|
-.--% | +9,900.00% |
| 28/06/23 | Bionik Laboratories Corp. Announces Executive Changes | CI |
| 22/06/23 | Bionik Laboratories Corp. Reports Earnings Results for the Full Year Ended March 31, 2023 | CI |
| Market Cap | 12 10.5 9.68 8.96 17 1.15K 17.28 115.93 45.45 562.48 45.05 44.07 1.95K | P/E 2022 |
-0.21x | P/E 2023 | -0.56x |
|---|---|---|---|---|---|
| Enterprise Value | 1.98M 1.74M 1.6M 1.48M 2.81M 189M 2.86M 19.18M 7.52M 93.04M 7.45M 7.29M 322M | EV / Sales 2022 |
0.17x | EV / Sales 2023 | 2.65x |
| Free-Float |
100% | Yield 2022 * |
-
| Yield 2023 | - |
| 1 day | +9,900.00% |
| Current year | 0 | 0 | |
| 1 year | 0 | 0 | |
| 3 years | 0 | 0.5 | |
| 5 years | 0 | 2.9 | |
| 10 years | 0 | 222.02 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Russo
CEO | Chief Executive Officer | 46 | 14/07/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Michal Prywata
BRD | Director/Board Member | 35 | 18/03/2019 |
| Director/Board Member | 70 | 01/09/2017 | |
Richard Russo
BRD | Director/Board Member | 46 | 13/10/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 13/06/23 | Conversion | Chairman | 186,112 | 1.4416% | ||
| 13/06/23 | Conversion | Director | 3,102,878 | 24.0337% | ||
| 09/06/23 | Buy | Director | 180,555 | 1.3985% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +9,900.00% | -.--% | -.--% | -99.98% | 1.26K | ||
| +2.86% | +0.24% | +24.97% | +2.14% | 195B | ||
| -0.86% | -3.39% | -22.07% | +24.23% | 146B | ||
| +0.40% | -0.33% | -56.30% | -13.96% | 66.87B | ||
| -2.47% | -3.22% | +18.32% | +1.19% | 52.59B | ||
| +0.95% | -0.77% | -27.48% | -30.20% | 43.85B | ||
| +3.50% | +2.22% | +10.13% | +14.18% | 37.73B | ||
| +2.44% | -0.57% | +8.00% | +42.77% | 37.03B | ||
| +1.27% | -0.56% | -18.57% | -3.41% | 30.07B | ||
| +0.03% | -1.32% | -14.32% | -18.74% | 29.43B | ||
| Average | +990.54% | -1.70% | -7.73% | -8.18% | 63.83B | |
| Weighted average by Cap. | +0.01% | -1.81% | -4.16% | +5.04% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 1.27M 1.11M 1.03M 951K 1.8M 122M 1.83M 12.31M 4.82M 59.7M 4.78M 4.68M 207M | 1.81M 1.58M 1.46M 1.35M 2.56M 172M 2.6M 17.44M 6.84M 84.62M 6.78M 6.63M 293M |
| Net income | -10.41M -9.1M -8.4M -7.77M -14.75M -993M -14.99M -101M -39.42M -488M -39.07M -38.23M -1.69B | -4.95M -4.33M -3.99M -3.69M -7.01M -472M -7.12M -47.78M -18.73M -232M -18.57M -18.17M -803M |
| Net Debt | -1.99M -1.74M -1.61M -1.49M -2.82M -190M -2.87M -19.24M -7.54M -93.34M -7.48M -7.31M -323M | 1.98M 1.74M 1.6M 1.48M 2.81M 189M 2.86M 19.18M 7.52M 93.04M 7.45M 7.29M 322M |
Employees
12
- Stock Market
- Stocks
- BNKL Stock
Select your edition
All financial news and data tailored to specific country editions
















